CNO is proposing changes to its Nurse Practitioner (NP) practice standard, and we want to hear from you. These changes involve proposed accountabilities around the prescribing of safer supply medications. We are proposing these changes to prevent drug diversion and ensure that clients have the same experience whether they are being treated by a physician or a nurse practitioner.
Specifically, the proposed changes would add the following accountabilities to the standard:
- When prescribing opioids in conjunction with opioid agonist therapy (OAT), NPs must:
- perform an in-person assessment at least once monthly for clients receiving safer supply medication
- clearly note on prescriptions for safer supply medication “safer supply” and “no carries” (take-home doses) to communicate the intent and that each dose of safer supply medication be consumed under direct observation by a regulated health-care professional
We are also proposing to add definitions for OAT and safer supply in the NP practice standard’s glossary section.
Below you will find a link to a survey where you can share your feedback on these proposed changes. The deadline to complete the survey is November 5, 2026. We want to hear from you!
CNO’s Council (our Board of Directors) will consider your feedback and proposed changes to the NP standard at its December 2026 meeting.
A French version of this message and the survey itself are available upon request.